240 participants
A Phase I Safty and Immunogenicity Study of SCT1000 in Healthy Women Aged 18 to 45 Years
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-09-17
- Start Date:
- 2021-07-02
- Completion:
- 2022-07-31
Conditions
- HPV Infection Vaccine Safety SCT1000
Interventions
- DRUG
No Results Yet